Category: Federal Forum Posters
Purpose: COPD is a chronic, progressive inflammatory process that can lead to obstruction of the peripheral bronchus and pulmonary emphysema. Roughly 12 million adults in the United States are diagnosed with COPD. COPD is even more of an issue for Veterans because they are three times more likely to develop COPD compared to the general population. A past study has found that participation in a pharmacy-led COPD clinic improved adherence, decreased hospitalizations, and improved quality of life. The purpose of this study is to evaluate the impact of a pharmacist-run COPD clinic on patient outcomes within this healthcare facility.
Methods: Patients enrolled in the COPD clinic will be selected for inclusion in this analysis. Inclusion criteria for the COPD clinic consists of a diagnosis of COPD, FEV1/FVC < 0.70 (post bronchodilator) on spirometry, and willingness to attend one in-person visit. Patients were excluded if they were COPD treatment naïve, α-1 antitrypsin deficient, or unwilling or unable to attend at least one in-person visit.
Primary study endpoints include Medication Complexity Regimen Index scores and mean difference in COPD Assessment Test (CAT) scores. Secondary endpoints will include change in number of cigarettes per day, smoking status, immunization status, COPD exacerbation rates, and mean difference in adherence survey scores.
Results: Not applicable
Conclusion: Not applicable
Paige Meade– Pharmacy Student, Creighton University School of Pharmacy & Health Professions, Omaha, NE